LEND SRL
The score of LEND shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +149 % Total assets +4876 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LEND's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 30 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
LEND's financial analysis
- Solvency3.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LEND
LEND's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0793.992.708
- VAT number
- BE0793992708
- Peppol
- Registered · 0208:0793992708 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Nov 2022
- Registered office
- 3020 Herent
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
LEND (SRL) has been based in Herent since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 24,301 € and equity of 5,000 €; its revenue is not published. Its solvency stands at 3.0%, below the median of its sector (44.2%).
Companies similar to LEND
Companies in the same business, of comparable size and area, outside its group.
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- Joos Clinical Projects Manufacture of basic pharmaceutical products Destelbergen · balance sheet 549,074 €
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Temapharm Retail sale of pharmaceutical products Neupré · balance sheet 191,548 €
- Ansorius Retail sale of pharmaceutical products Bastogne · balance sheet 174,823 €
- Pharm'Training Lab Retail sale of pharmaceutical products Leuze-en-Hainaut · balance sheet 87,540 €
- Tupharma Connect AND Trade Retail sale of pharmaceutical products Ghent · balance sheet 95,322 €
- Antha Consult Retail sale of pharmaceutical products Liège · balance sheet 272,102 €
Frequently asked questions about LEND
What is the revenue of LEND?
LEND files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LEND?
In Belgium, the VAT number is the company number prefixed with BE: BE0793992708 for LEND, if the company is VAT-registered. Its company number (CBE) is 0793.992.708.
Where is the registered office of LEND?
According to the CBE register, the registered office of LEND is in 3020 Herent.
What is the equity of LEND?
At the close of the 2025 financial year, the equity of LEND amounts to 5,000 €, a solvency of 3.0% of total assets.
Who manages LEND?
The register lists 2 active mandates at LEND. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LEND
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →